El Rassy, Elie <br/><br/>
Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis.  [electronic resource] 

 -  Clinics and research in hepatology and gastroenterology  Mar 2017 
 - e26-e28 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>2210-741X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinre.2016.11.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Aged<br/>Albumins--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Camptothecin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Drug Combinations<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Irinotecan<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Organometallic Compounds--administration & dosage<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Paclitaxel--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Retrospective Studies<br/>Risk Factors<br/>Treatment Failure<br/>Treatment Outcome<br/>Gemcitabine